Morphosys

Developer of antibodies for treating cancer

placePlanegg, Bavaria, Germany calendar_todayFounded 1992 groups732 employees language morphosys.com

Registered entities

Investor mix

10 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital550%
Private equity330%
Accelerator & incubator110%
Other / undisclosed110%
Coming soon